Pages that link to "Q35995979"

The following pages link to Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. (Q35995979):

Displaying 29 items.

• Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics (Q26799532) (← links)
• Corchorus Olitorius Linn: A Rich Source of Ω3-Fatty Acids (Q28822410) (← links)
• Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients (Q30418087) (← links)
• Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases (Q33838866) (← links)
• Retracted: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients (Q34081393) (← links)
• Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients (Q34293248) (← links)
• Ethnic disparities in liver transplantation. (Q35078994) (← links)
• The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients (Q35612903) (← links)
• Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects (Q35987461) (← links)
• Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. (Q36204611) (← links)
• The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients (Q36513703) (← links)
• Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics (Q36597641) (← links)
• Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium (Q36630081) (← links)
• Genotype-guided tacrolimus dosing in African-American kidney transplant recipients (Q37009025) (← links)
• Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients (Q37439873) (← links)
• Liver transplantation in the ethnic minority population: challenges and prospects (Q37458352) (← links)
• TAC-TIC use of tacrolimus-based regimens in lupus nephritis (Q37587317) (← links)
• Recipient-based approach to tailoring immunosuppression in liver transplantation (Q37771615) (← links)
• Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment (Q38501680) (← links)
• Renal transplantation in emigrants from Africa in Spain: similar results but different infectious profile compared with Spanish people. (Q39287053) (← links)
• Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation (Q41355218) (← links)
• Using Genetic and Clinical Factors to Predict Tacrolimus Dose in Renal Transplant Recipients (Q42837771) (← links)
• African American renal transplant recipients (RTR) require higher tacrolimus doses to achieve target levels compared to white RTR: does clotrimazole help? (Q43689301) (← links)
• An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma (Q44010283) (← links)
• Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients (Q46606824) (← links)
• Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation (Q82978464) (← links)
• Unusual high dose of tacrolimus in liver transplant patient, a case report (Q83665997) (← links)
• Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study (Q92039749) (← links)
• Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1) (Q92351245) (← links)